Olaf KoenigExecutive Director at Amgen
Olaf Koenig serves as Executive Director in Business Development at Amgen. As part of the global transaction team, he focusses on international and ex-US business development transactions. He is based in Amgen’s European Headquarter in Rotkreuz, Switzerland.
He has over 25 years of international experience in a variety of business development and commercial roles, and a track record of leading and closing of several in-licensing, out-licensing and M&A transactions. Prior to joining Amgen, Olaf was Vice President, Business Development & New Product Planning Europe at Daiichi Sankyo. Before joining Daiichi Sankyo, he served as Director Business Development at Merck KGaA. Olaf began his career as Product Manager at Molecular Simulations in Cambridge, UK. Olaf holds a PhD in Chemistry from the University of Berne, Switzerland.